Large-scale testing (Phase 3)Study completedNCT04449861What this trial is testingDurvalumab Plus Chemotherapy in ES-SCLC (Oriental)Who this might be right forSmall Cell Lung Carcinoma Extensive Disease AstraZeneca 166
Large-scale testing (Phase 3)Not Yet RecruitingNCT07106528What this trial is testingOrganoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung CancerWho this might be right forExtensive-stage Small Cell Lung Cancer (ES-SCLC)Extensive-stage Small Cell Lung Cancer (SCLC)Small Cell Lung Cancer ( SCLC ) Peking Union Medical College Hospital 128
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07547332What this trial is testingNab-Paclitaxel Combined With Local Therapy in Relapsed SCLCWho this might be right forSmall Cell Lung CancerExtensive Stage Small Cell Lung Cancer (ES-SCLC) Shanghai Pulmonary Hospital, Shanghai, China 84
Not applicableNot Yet RecruitingNCT06982287What this trial is testingA Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059)Who this might be right forSmall Cell Lung Cancer Extensive Stage Yong Fang 100
Testing effectiveness (Phase 2)Looking for participantsNCT06749691What this trial is testingLiposomal Irinotecan and Apatinib in ES-SCLCWho this might be right forSmall Cell Lung Cancer Extensive Stage Second Affiliated Hospital, School of Medicine, Zhejiang University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07339059What this trial is testingStudy of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung CancerWho this might be right forSmall Cell Lung Cancer ( SCLC )Extensive Stage Small Cell Lung Cancer (ES-SCLC) Bindu R Potugari 35
Early research (Phase 1)UnknownNCT05001412What this trial is testingChemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLCWho this might be right forExtensive Stage Small Cell Lung Cancer Zhou Chengzhi 36
Testing effectiveness (Phase 2)Looking for participantsNCT06769971What this trial is testingPhase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLCWho this might be right forSmall Cell Lung Cancer Sichuan University 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06332950What this trial is testingSafety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With ImmunotherapyWho this might be right forExtensive-stage Small-cell Lung Cancer Baohui Han 80
Testing effectiveness (Phase 2)Looking for participantsNCT06217757What this trial is testingSafety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLCWho this might be right forLung CancerExtensive-stage Small-cell Lung Cancer Sichuan University 45
Early research (Phase 1)Study completedNCT05116007What this trial is testingAnti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLCWho this might be right forSCLC, Extensive Stage Akeso 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07289048What this trial is testingA Prospective, Single-Arm, Exploratory Study of IBI363 in ES-SCLC Patients After Immunotherapy ProgressionWho this might be right forSCLC,Extensive Stage Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 35
Testing effectiveness (Phase 2)UnknownNCT04698941What this trial is testingCombined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st ChemotherapyWho this might be right forSmall Cell Lung Cancer Shanghai Pulmonary Hospital, Shanghai, China 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04334941What this trial is testingTesting Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive BiomarkerWho this might be right forExtensive Stage Lung Small Cell Carcinoma National Cancer Institute (NCI) 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT05092412What this trial is testingLow-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLCWho this might be right forLung CancerExtensive-stage Small-cell Lung CancerDurvalumab You Lu 30
Testing effectiveness (Phase 2)UnknownNCT05731518What this trial is testingSC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)Who this might be right forSmall Cell Lung Cancer Biocity Biopharmaceutics Co., Ltd. 67
Testing effectiveness (Phase 2)Ended earlyNCT06939036What this trial is testingStudy of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )Who this might be right forSmall Cell Lung Cancer Extensive StageMerkel Cell Carcinoma Ariceum Therapeutics GmbH 2
Early research (Phase 1)Not Yet RecruitingNCT07063407What this trial is testingPhase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung CancerWho this might be right forExtensive Stage Small Cell Lung Cancer (ES-SCLC) Shanghai Hansoh Biomedical Co., Ltd 50
Not applicableLooking for participantsNCT05552846What this trial is testingPhase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapyWho this might be right forSmall-cell Lung Cancer Ruijin Hospital 104
Large-scale testing (Phase 3)Active Not RecruitingNCT06211036What this trial is testingStudy Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and DurvalumabWho this might be right forExtensive-Stage Small-Cell Lung CancerSmall-Cell Lung Cancer Amgen 563